Vitrue Health, a digital platform for musculoskeletal (MSK) health in the workplace, has secured an additional $4m (£3.2m) in funding from investors such as MMC Ventures and Hambro Perks, bringing their total raised to $7m (£5.56m). MSK conditions are widespread and can be painful for employees and costly for employers, accounting for 24% of all work-related ill health issues and resulting in 30 million lost work days per year in the UK alone. Vitrue Health focuses on preventing and resolving MSK conditions before they become problematic by using advanced motion capture technology, biomechanics, computer vision and AI to analyse workers’ ergonomics, behaviour and risks, and offering personalised programmes covering equipment use, injury management, and psychology. The platform has seen a 92% reduction in pain for users. The funding will be used to expand Vitrue Health’s team and extend its reach across Europe and the US, as well as research new clinical use cases. Co-founder and CEO Shane Lowe said the platform aims to reduce the financial and health costs of MSK conditions for employers and employees.
Transition words: In addition, Widespread, Furthermore, Moreover, As a result, Additionally, Therefore, However, Meanwhile, Consequently
Active voice: Vitrue Health has secured $4m in funding, with investors such as MMC Ventures and Hambro Perks leading the round and Simplyhealth Ventures, Crista Galli Ventures, and Chris Bruce also involved. Workers’ ergonomics, behavior, and risks are analyzed, and personalized programs covering equipment use, injury management, and psychology are provided. Users have reported a 92% reduction in pain. The platform is expanding its team and reach across Europe and the US, as well as researching new clinical use cases. CEO Shane Lowe said the platform aims to reduce the financial and health costs of MSK conditions for employers and employees, and MSK disorders account for 24% of all working days lost due to work-related ill health, resulting in 30 million lost work days per year. Vitrue Health was developed using advanced motion capture technology, biomechanics, computer vision, and AI.
Paragraphs:
Vitrue Health, a digital platform for musculoskeletal (MSK) health in the workplace, has secured an additional $4m (£3.2m) in funding from investors such as MMC Ventures and Hambro Perks, bringing their total raised to $7m (£5.56m). MSK disorders, which can be painful for employees and costly for employers, are widespread and account for 24% of all working days lost due to work-related ill health, with British employers losing 30 million work days every year.
Vitrue Health focuses on preventing and resolving MSK conditions before they become problematic by using advanced motion capture technology developed following co-founder Shane Lowe’s PhD, biomechanics inspired by co-founder Alexandra Haslehurst’s masters degree from Cambridge University, computer vision, and AI to analyze workers’ ergonomics, behavior, and risks. This digital platform offers personalized programmes covering equipment use, injury management, and psychology, with a 92% reduction in pain for users.
The new funding will be used to grow Vitrue Health’s team and broaden its reach across Europe and the US, and research new clinical use cases. Vitrue Health aims to reduce the financial and health costs of MSK conditions for employers and employees. CEO Shane Lowe said that the rise of hybrid working has massively increased rates of pain, and Vitrue Health seeks to address this global problem. Simon Menashy, partner at MMC Ventures, praised the team’s technical and clinical expertise and said Vitrue Health had found a strong use case with an evidenced product-market fit that can help eliminate musculoskeletal pain for millions of people. Nick Sharp, partner at Hambro Perks, commented that Vitrue Health has made great progress in resolving a global pain point and stands out for its unique tech solution.